Top news of the week: 11.08.2020.
#news #pharma #pharmiweb #cattle #agtech #biotech #geneediting #Biotechnology #crispr
Career And Jobs
@Jasonmmast spoke with @JMaraganore about Barry Greene's departure:
“Leading Alnylam in the future, I’m going to feel like I’m doing it without my right arm. But I’m so blessed to have this broader team that we built.”
https://t.co/PPuEeDuDGt
OpenAlnylam president Barry Greene leaves after 17 years, handing position over to Yvonne Greenstreet as biotech looks toward profitability
After 17 years helping Alnylam steer control of buzzy but unproven science they promised could change medicine, president Barry Greene is leaving the RNAi biotech just as that technology is ...
A good look at the improvements that are possible, and what is needed to achieve them: "Biotechnology Could Change the Cattle Industry. Will it Succeed?" https://t.co/UhRDWd7Cii via @undarkmag #agtech #biotech #cattle https://t.co/qnEs9yU1rx
OpenBiotechnology Could Change the Cattle Industry. Will it Succeed?
Gene editing could help scientists produce cows that are meatier and better for the planet. But many hurdles remain.
Viva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Escalation of the Service Chain of Innovative Drug Industry
https://t.co/FmczsieWDX
#news #pharma #pharmiweb
OpenViva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Escalation of the Service Chain of Innovative Drug Industry
SHANGHAI, Aug. 10, 2020 /PRNewswire/ -- On August 9th, 2020, Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to as "Viva Biotech" or "The Company") entered into the Share Purchase ...
COVID -19 Update : Aptamers Market 2020-2026 Detailed Analysis of Current and Future Industry Figures || Leading Players – NeoVentures Biotechnology Inc., SOMALOGIC, INC., TriLink BioTechnologies, LLC, Vivonics Inc., NOXXON Pharma
https://t.co/dBfgxlmJDR
#news #pharma #pharmiweb
OpenCOVID -19 Update : Aptamers Market 2020-2026 Detailed Analysis of Current and Future Industry Figures || Leading Players – NeoVentures Biotechnology Inc., SOMALOGIC, INC., TriLink BioTechnologies, LLC, Vivonics Inc., NOXXON Pharma
Aptamers Market report provides one of the greatest solutions to know the trends and opportunities in Healthcare industry. In this Aptamers Market document, the competition in the global ...
CureVac nabs a top Novartis scientist for CSO slot as mRNA vaccines seize the spotlight
https://t.co/C4Q6AtZ8Mu
OpenCureVac nabs a top Novartis scientist for CSO slot as mRNA vaccines seize the spotlight
One of the key players in the race to develop a new mRNA vaccine to fight Covid-19 has reshuffled the top spots in the executive suite. And they’re bringing in a Novartis vet out of Harvard ...
I've been waiting for this one: Biogen hands Denali $1B-plus in cash, $1B-plus in milestones to partner on late-stage Parkinson’s drug
$BIIB $DNLI +40%
https://t.co/bFtsNM4YIq
OpenBiogen hands Denali $1B-plus in cash, $1B-plus in milestones to partner on late-stage Parkinson’s drug
Biogen is handing over more than a billion dollars cash to partner with the up-and-coming neurosciences crew at Denali on a new therapy for Parkinson’s. And the big biotech is ready to pile ...
Bioregnum:
'October is coming,' and everyone still wants to know if a Covid-19 vaccine will be whisked through the FDA ahead of the election
https://t.co/Z0nsVLjSdi
Open'October is coming,' and everyone still wants to know if a Covid-19 vaccine will be whisked through the FDA ahead of the election
Right on the heels of a lengthy assurance from FDA commissioner Stephen Hahn that the agency will not rush through a quick approval for a Covid-19 vaccine, the President of the United ...
#2
Covid-19 roundup: 34 AGs call for ‘march-in’ rights on remdesivir; Hahn pleads with public to trust FDA's vaccine review
https://t.co/F0boT6QJfI
OpenCovid-19 roundup: 34 AGs call for ‘march-in’ rights on remdesivir; Hahn pleads with public to trust FDA's vaccine review
A bipartisan group of 34 attorneys general have asked the federal government to bypass Gilead’s patent rights on remdesivir and begin scaling and distributing the Covid-19 antiviral, or to ...